Richard Earl Parrish, MD, FCCP Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1800 Medical Center Pkwy Ste 310, Murfreesboro, TN 37129 Phone: 615-849-9868 Fax: 615-898-1882 |
Ray Charles Johnson, MD, FCCP Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 310, Murfreesboro, TN 37129 Phone: 615-849-9868 Fax: 615-898-1882 |
Dr. Johann Christoph Brandes, MD, PHD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Medical Center Pkwy, Suite 300, Murfreesboro, TN 37129 Phone: 615-848-0488 Fax: 615-904-9061 |
Frank Blonvil Louthan Iii, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 310, Murfreesboro, TN 37129 Phone: 615-849-9868 Fax: 615-898-1882 |
Dr. Carl A Green Jr., MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 3400 Lebanon Pike, Murfreesboro, TN 37129 Phone: 615-848-0428 |
News Archive
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
Our gut microbiomes-the bacteria that live in our digestive tract-play major roles in our health. Scientists around the world are studying therapies that manipulate the microbiome, including probiotics (such as live bacterial cultures in yogurt), prebiotics (edible fibers meant to promote beneficial bacteria), antibiotics and transplants of microbes from healthy people.
Researchers have found that injecting aorta-derived stem cells into the hearts of dystrophin-deficient mice prevents the onset of dilated cardiomyopathy, raising hopes of a potential new treatment approach to prevent or reverse the condition in human Duchenne muscular dystrophy.
The coronavirus disease (COVID-19) pandemic first emerged in a seafood market in Wuhan City, Hubei Province, China, in December 2019. Since then, it has spread to 188 countries and territories and infected more than 10 million people. The viral infection has so far killed more than 500,000 people worldwide.
When Furman Professor of Physics Bill Baker was diagnosed with Type 2 diabetes in 2003, it served as an initiation into a painful club.
› Verified 4 days ago